Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Blaiss

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 17, 2015
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and childrenJacques Hébert, Michael Blaiss, Susan Waserman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 1, 2012
The CHOICE survey: high rates of persistent and uncontrolled asthma in the United StatesGene L Colice, Nancy K Ostrom, David E Geller, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 20, 2015
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitisHarold Kim, Susan Waserman, Jacques Hébert, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 5, 2005
Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitisEli O Meltzer, James Hadley, Michael Blaiss, et al.
The World Allergy Organization Journal|December 27, 2012
Climate change, migration, and allergic respiratory diseases: an update for the allergistGennaro D'Amato, Menachem Rottem, Ronald Dahl, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 10, 2006
Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and ImmunologyLeonard Bielory, Michael Blaiss, Stanley M Fineman, et al.
The Journal of Allergy and Clinical Immunology|December 10, 2017
Effect of grass sublingual tablet immunotherapy is similar in children and adults: A Bayesian approach to design pediatric sublingual immunotherapy trialsAmarjot Kaur, David Skoner, Joseph Ibrahim, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 10, 2023
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatmentMichael Blaiss, John Oppenheimer, Mark Corbett, et al.
Allergy and Asthma Proceedings|May 17, 2024
Real-world effectiveness of dupilumab versus benralizumab and mepolizumabEugene Bleecker, Michael Blaiss, Juby Jacob-Nara, et al.
International Forum of Allergy & Rhinology|October 29, 2025
The Influence of Nasal Cavity Dimensions on Frequency of Treatment for Rhinitis SymptomsLirit Levi, Vivek Mohan, Yifei Ma, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 17, 2015
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and childrenJacques Hébert, Michael Blaiss, Susan Waserman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 1, 2012
The CHOICE survey: high rates of persistent and uncontrolled asthma in the United StatesGene L Colice, Nancy K Ostrom, David E Geller, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 20, 2015
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitisHarold Kim, Susan Waserman, Jacques Hébert, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 5, 2005
Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitisEli O Meltzer, James Hadley, Michael Blaiss, et al.
The World Allergy Organization Journal|December 27, 2012
Climate change, migration, and allergic respiratory diseases: an update for the allergistGennaro D'Amato, Menachem Rottem, Ronald Dahl, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 10, 2006
Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and ImmunologyLeonard Bielory, Michael Blaiss, Stanley M Fineman, et al.
The Journal of Allergy and Clinical Immunology|December 10, 2017
Effect of grass sublingual tablet immunotherapy is similar in children and adults: A Bayesian approach to design pediatric sublingual immunotherapy trialsAmarjot Kaur, David Skoner, Joseph Ibrahim, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 10, 2023
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatmentMichael Blaiss, John Oppenheimer, Mark Corbett, et al.
Allergy and Asthma Proceedings|May 17, 2024
Real-world effectiveness of dupilumab versus benralizumab and mepolizumabEugene Bleecker, Michael Blaiss, Juby Jacob-Nara, et al.
International Forum of Allergy & Rhinology|October 29, 2025
The Influence of Nasal Cavity Dimensions on Frequency of Treatment for Rhinitis SymptomsLirit Levi, Vivek Mohan, Yifei Ma, et al.
Pageof 5